A new study suggests that previous research has underestimated the incidence of severe combined immunodeficiency. One in every 100,000 newborns had been thought to have the condition. But based on the results of T-cell testing for more than 3 million infants, the rate appears to be one out of every 58,000 babies. Early detection and treatments such as transplants, enzyme replacement or gene therapy were associated with better survival in SCID infants, according to the study in the Journal of the American Medical Association.

Full Story:

Related Summaries